Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of

提高低风险支气管活检评估的诊断率

基本信息

  • 批准号:
    8654306
  • 负责人:
  • 金额:
    $ 52.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-19 至 2018-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer related death accounting for more deaths than breast, prostate and colon combined. Early diagnosis is critical to patient survival, however the vast majority of lung malignancies are detected only once symptoms arise and the cancer has spread, at which time patients have little chance of cure. Macroscopic imaging modalities including CT and bronchoscopy have made significant strides in increasing early detection; however they do not have the required specificity to diagnose malignancy. Diagnosis must be made on the microscopic level, which at present can only be accomplished with excisional biopsy. Unfortunately, low-risk bronchoscopic techniques for retrieving biopsy samples are hampered by low diagnostic yields, and trans-thoracic and surgical approaches carry higher intrinsic risk of complications. Given the very high false positive rates of these macroscopic imaging platforms it is imperative that high-risk procedures are avoided and the diagnostic accuracy of lower-risk approaches is greatly improved. In this proposal we aim to dramatically increase the diagnostic yield of low-risk bronchial biopsy using novel optical imaging tools to locally guide biopsy site selection ensuring that diagnostic quality samples are obtained for both histopathology and molecular profiling. Specifically, we will develop and translate polarization-sensitive optical frequency domain imaging (PS-OFDI) systems, and novel catheters for conducting PS-OFDI of the airways and peripheral lung. We will develop and validate diagnostic criteria for evaluating the PS-OFDI images of lung cancer pathology, and we will conduct clinical studies to demonstrate the improvement in biopsy yield over conventional approaches. This work will leverage the expertise, resources and ongoing collaborative ties between investigators at Massachusetts General Hospital and NinePoint Medical. Together the strategic alliance already formed will ensure the successful translation and delivery of a powerful and robust new optical bronchoscopy tool that will likely result in an increase in the diagnostic yield of bronchial biopsy for the assessment of lung cancer.
描述(由申请人提供):肺癌是癌症相关死亡的主要原因,其死亡人数超过乳腺癌、前列腺癌和结肠癌的总和。早期诊断对于患者的生存至关重要,然而,绝大多数肺部恶性肿瘤只有在症状出现且癌症扩散时才被发现,此时患者治愈的机会很小。包括 CT 和支气管镜检查在内的宏观成像方式在提高早期发现方面取得了重大进展;然而,它们不具备诊断恶性肿瘤所需的特异性。诊断必须在显微镜水平上进行,目前只能通过切除活检来完成。不幸的是,用于检索活检样本的低风险支气管镜技术受到低诊断率的阻碍,并且经胸和手术方法具有较高的并发症内在风险。鉴于这些宏观成像平台的误报率非常高,必须避免高风险程序,并大大提高低风险方法的诊断准确性。在本提案中,我们的目标是使用新型光学成像工具显着提高低风险支气管活检的诊断率,以局部指导活检部位选择,确保诊断质量 获得样品用于组织病理学和分子分析。具体来说,我们将开发和转化偏振敏感光频域成像(PS-OFDI)系统,以及用于对气道和周围肺进行 PS-OFDI 的新型导管。我们将制定并验证评估肺癌病理学 PS-OFDI 图像的诊断标准,并且我们将进行临床研究,以证明活检产量比传统方法有所提高。这项工作将利用马萨诸塞州总医院和 NinePoint Medical 的研究人员之间的专业知识、资源和持续的合作关系。已经形成的战略联盟将确保成功转化和交付强大而强大的新型光学支气管镜工具,这可能会提高用于评估肺癌的支气管活检的诊断率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brett E Bouma其他文献

Technology Insight: optical coherence tomography—current status and future development
技术洞察:光学相干断层扫描——现状与未来发展
  • DOI:
    10.1038/ncpcardio0482
  • 发表时间:
    2006-03-01
  • 期刊:
  • 影响因子:
    44.200
  • 作者:
    Adrian F Low;Guillermo J Tearney;Brett E Bouma;Ik-Kyung Jang
  • 通讯作者:
    Ik-Kyung Jang

Brett E Bouma的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brett E Bouma', 18)}}的其他基金

Dual-modality FLIm and PSOCT for intravascular imaging of plaque in patients
双模态 FLIm 和 PSOCT 用于患者斑块血管内成像
  • 批准号:
    10677774
  • 财政年份:
    2021
  • 资助金额:
    $ 52.95万
  • 项目类别:
Dual-modality FLIm and PSOCT for intravascular imaging of plaque in patients
双模态 FLIm 和 PSOCT 用于患者斑块血管内成像
  • 批准号:
    10306091
  • 财政年份:
    2021
  • 资助金额:
    $ 52.95万
  • 项目类别:
Center for Biomedical OCT Research and Translation
生物医学OCT研究与转化中心
  • 批准号:
    9521706
  • 财政年份:
    2017
  • 资助金额:
    $ 52.95万
  • 项目类别:
Intracoronary imaging of plaque collagen in patients
患者斑块胶原的冠状动脉内成像
  • 批准号:
    8735353
  • 财政年份:
    2014
  • 资助金额:
    $ 52.95万
  • 项目类别:
Intracoronary imaging of plaque collagen in patients
患者斑块胶原的冠状动脉内成像
  • 批准号:
    9263997
  • 财政年份:
    2014
  • 资助金额:
    $ 52.95万
  • 项目类别:
Intracoronary imaging of plaque collagen in patients
患者斑块胶原的冠状动脉内成像
  • 批准号:
    8842192
  • 财政年份:
    2014
  • 资助金额:
    $ 52.95万
  • 项目类别:
Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of
提高低风险支气管活检评估的诊断率
  • 批准号:
    8531402
  • 财政年份:
    2013
  • 资助金额:
    $ 52.95万
  • 项目类别:
Center for Biomedical OCT Research and Translation
生物医学OCT研究与转化中心
  • 批准号:
    10494619
  • 财政年份:
    2011
  • 资助金额:
    $ 52.95万
  • 项目类别:
Center for Biomedical OCT Research and Translation
生物医学OCT研究与转化中心
  • 批准号:
    8078519
  • 财政年份:
    2011
  • 资助金额:
    $ 52.95万
  • 项目类别:
Administration
行政
  • 批准号:
    10650833
  • 财政年份:
    2011
  • 资助金额:
    $ 52.95万
  • 项目类别:

相似海外基金

卵巣癌/子宮体癌における薬剤感受性メチル化診断キットの開発とLiquid Biopsyへの応用
卵巢癌/子宫内膜癌药物敏感甲基化诊断试剂盒的研制及其在液体活检中的应用
  • 批准号:
    24K02584
  • 财政年份:
    2024
  • 资助金额:
    $ 52.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
グリオーマのliquid biopsyによるメチル化網羅的解析とprecision medicineへの応用
胶质瘤液体活检甲基化综合分析及其在精准医疗中的应用
  • 批准号:
    24K12271
  • 财政年份:
    2024
  • 资助金额:
    $ 52.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis (MONALISA)
SIOPEN 通过液体活检敏感性分析 (MONALISA) 监测神经母细胞瘤复发的实用临床试验
  • 批准号:
    10110442
  • 财政年份:
    2024
  • 资助金额:
    $ 52.95万
  • 项目类别:
    EU-Funded
MONALISA: A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
MONALISA:一项 SIOPEN 实用临床试验,通过液体活检监测神经母细胞瘤复发 敏感性分析
  • 批准号:
    10103126
  • 财政年份:
    2024
  • 资助金额:
    $ 52.95万
  • 项目类别:
    EU-Funded
精神的長期ストレス児童の口腔細菌叢と唾液成分の解析:唾液 liquid biopsyを目指して
长期精神应激儿童口腔菌群和唾液成分分析:唾液液体活检
  • 批准号:
    24K13206
  • 财政年份:
    2024
  • 资助金额:
    $ 52.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Liquid biopsyを用いた炎症性腸疾患の早期診断法開発
液体活检炎症性肠病早期诊断方法的开发
  • 批准号:
    24K10595
  • 财政年份:
    2024
  • 资助金额:
    $ 52.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mutated human oncogene recombinant nucleosomes as reference materials for liquid biopsy
突变人癌基因重组核小体作为液体活检参考材料
  • 批准号:
    10090714
  • 财政年份:
    2024
  • 资助金额:
    $ 52.95万
  • 项目类别:
    Collaborative R&D
肝細胞癌における術中門脈血を用いたliquid biopsyの検討
肝细胞癌术中门静脉血液体活检检查
  • 批准号:
    24K19404
  • 财政年份:
    2024
  • 资助金额:
    $ 52.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Genetic diagnosis of vascular malformations by liquid biopsy and its application to precision medicine
液体活检对血管畸形的基因诊断及其在精准医疗中的应用
  • 批准号:
    23K09072
  • 财政年份:
    2023
  • 资助金额:
    $ 52.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Breath biopsy technology targeting for volatile oxidized lipids
针对挥发性氧化脂质的呼吸活检技术
  • 批准号:
    23K06080
  • 财政年份:
    2023
  • 资助金额:
    $ 52.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了